Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$14.88 - $20.13 $3.48 Million - $4.71 Million
-233,840 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $65,565 - $101,032
4,926 Added 2.15%
233,840 $4.27 Million
Q1 2020

May 28, 2020

BUY
$12.98 - $30.25 $2.97 Million - $6.92 Million
228,914 New
228,914 $3.55 Million
Q1 2020

May 15, 2020

SELL
$12.98 - $30.25 $3.04 Million - $7.08 Million
-234,026 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$20.52 - $26.45 $162,272 - $209,166
-7,908 Reduced 3.27%
234,026 $5.92 Million
Q4 2018

Feb 11, 2019

SELL
$17.64 - $28.32 $24,819 - $39,846
-1,407 Reduced 0.58%
241,934 $4.48 Million
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $5.02 Million - $6.25 Million
243,341 New
243,341 $6.24 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.88B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.